AU3760100A - Immunostimulatory nucleic acids and antigens - Google Patents

Immunostimulatory nucleic acids and antigens

Info

Publication number
AU3760100A
AU3760100A AU37601/00A AU3760100A AU3760100A AU 3760100 A AU3760100 A AU 3760100A AU 37601/00 A AU37601/00 A AU 37601/00A AU 3760100 A AU3760100 A AU 3760100A AU 3760100 A AU3760100 A AU 3760100A
Authority
AU
Australia
Prior art keywords
antigens
nucleic acids
immunostimulatory nucleic
immunostimulatory
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37601/00A
Inventor
Michael J. Caplan
Howard B. Sosin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panacea Pharmaceuticals LLC
Original Assignee
Panacea Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US12459599P priority Critical
Priority to US60124595 priority
Priority to US12507199P priority
Priority to US60125071 priority
Application filed by Panacea Pharmaceuticals LLC filed Critical Panacea Pharmaceuticals LLC
Priority to PCT/US2000/007213 priority patent/WO2000054803A2/en
Publication of AU3760100A publication Critical patent/AU3760100A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/38Antigens from snakes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55561CpG containing adjuvants; Oligonucleotide containing adjuvants
AU37601/00A 1999-03-16 2000-03-16 Immunostimulatory nucleic acids and antigens Abandoned AU3760100A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US12459599P true 1999-03-16 1999-03-16
US60124595 1999-03-16
US12507199P true 1999-03-17 1999-03-17
US60125071 1999-03-17
PCT/US2000/007213 WO2000054803A2 (en) 1999-03-16 2000-03-16 Immunostimulatory nucleic acids and antigens

Publications (1)

Publication Number Publication Date
AU3760100A true AU3760100A (en) 2000-10-04

Family

ID=26822754

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37601/00A Abandoned AU3760100A (en) 1999-03-16 2000-03-16 Immunostimulatory nucleic acids and antigens

Country Status (2)

Country Link
AU (1) AU3760100A (en)
WO (1) WO2000054803A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US7935675B1 (en) 1994-07-15 2011-05-03 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6589940B1 (en) 1997-06-06 2003-07-08 Dynavax Technologies Corporation Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
WO1999061056A2 (en) 1998-05-22 1999-12-02 Loeb Health Research Institute At The Ottawa Hospital Methods and products for inducing mucosal immunity
DE60044236D1 (en) 1999-02-17 2010-06-02 Csl Ltd Immunogenic complex and methods with respect to these
EP1204425B1 (en) 1999-08-19 2009-01-07 Dynavax Technologies Corporation Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
WO2001022972A2 (en) * 1999-09-25 2001-04-05 University Of Iowa Research Foundation Immunostimulatory nucleic acids
AU1951201A (en) * 1999-12-06 2001-06-12 Mount Sinai School Of Medicine Of The City University Of New York, The Peptide antigens
US7129222B2 (en) 2000-03-10 2006-10-31 Dynavax Technologies Corporation Immunomodulatory formulations and methods for use thereof
US20030129251A1 (en) 2000-03-10 2003-07-10 Gary Van Nest Biodegradable immunomodulatory formulations and methods for use thereof
CA2403292C (en) * 2000-04-06 2011-02-08 Panacea Pharmaceuticals, Llc Microbial delivery system
JP4188687B2 (en) 2000-12-27 2008-11-26 ダイナバックス テクノロジーズ コーポレイション Immune modulation polynucleotides and methods of use thereof
ES2487645T3 (en) 2001-06-21 2014-08-22 Dynavax Technologies Corporation chimeric immunomodulatory compounds and methods of use thereof
AU2002326561B2 (en) 2001-08-07 2008-04-03 Dynavax Technologies Corporation Immunomodulatory compositions, formulations, and methods for use thereof
EP2196217A1 (en) 2001-09-14 2010-06-16 Cytos Biotechnology AG Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
JP2005526497A (en) 2002-02-04 2005-09-08 ビオミラ,インコーポレーテッド Immunostimulatory, covalent lipid oligonucleotide
US7807803B2 (en) 2002-07-03 2010-10-05 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US20040053880A1 (en) 2002-07-03 2004-03-18 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
AT544466T (en) 2002-10-29 2012-02-15 Coley Pharm Group Inc Use of CpG oligonucleotides for treatment of hepatitis C virus infection
CA2502015A1 (en) 2002-12-11 2004-06-24 Coley Pharmaceutical Group, Inc. 5' cpg nucleic acids and methods of use
US8158768B2 (en) 2002-12-23 2012-04-17 Dynavax Technologies Corporation Immunostimulatory sequence oligonucleotides and methods of using the same
CN100546998C (en) 2002-12-23 2009-10-07 戴纳伐克斯技术股份有限公司 Immunostimulatory sequence oligonucleotides and methods of using the same
WO2005121166A1 (en) * 2004-06-10 2005-12-22 Monash University Novel immunointeractive molecules and uses thereof
AU2005252268B2 (en) * 2004-06-10 2012-06-28 Aravax Pty Limited Novel immunointeractive molecules and uses thereof
SI2032592T1 (en) 2006-06-12 2013-10-30 Cytos Biotechnology Ag Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages
RU2451523C2 (en) 2005-12-14 2012-05-27 Цитос Биотехнологи Аг Particles packed in immunostimulating nucleic acid that intended for hypersensitivity treatment
NZ575437A (en) 2006-09-27 2012-02-24 Coley Pharm Gmbh Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
US9597385B2 (en) 2012-04-23 2017-03-21 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
CN105188741A (en) 2013-04-03 2015-12-23 阿勒丁医疗公司 Novel nanoparticle compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338297A (en) * 1980-02-19 1982-07-06 Michael Jacob G Polypeptide active pollen immunosuppressant fraction
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5
ES2326848T3 (en) * 1997-06-06 2009-10-20 Dynavax Technologies Corporation Inhibitors activity immunostimulatory DNA sequences.

Also Published As

Publication number Publication date
WO2000054803A2 (en) 2000-09-21
WO2000054803A3 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
EP2360252B8 (en) Immunostimulatory nucleic acid molecules comprising GTCGTT motifs
AU770360C (en) Vaccine composition
AU781501C (en) Anti-alphavbeta3recombinant human antibodies, nucleic acids encoding same and methods of use
AU775375C (en) DNA vaccine - PVC
AU696690B2 (en) Improved virus vaccines
AU5173400A (en) Protein kinases
GB9711957D0 (en) Methods and reagents for vaccination
GB9712347D0 (en) Vaccine
GB9727262D0 (en) Vaccine
GB9718901D0 (en) Vaccine
GB9711990D0 (en) Vaccine
PL339009A1 (en) Vaccine
AU2002239826A1 (en) Methods and reagents for the isolation of nucleic acids
AU2002245142A1 (en) Prokaryotically produced antibodies and uses thereof
HK1012398A1 (en) Phosphonomonoester nucleic acids, methods for their preparation and their use
AU9363798A (en) Neisserial antigens
AU2002309130A1 (en) Streptococcus pneumoniae proteins and nucleic acids
AUPQ801700A0 (en) Enzyme and viral activation
AU3150295A (en) Dna vaccines against rotavirus infections
AU7912100A (en) Pharmaceutical composition comprising an antigen
AU1290001A (en) Antibodies
EP0914153B8 (en) Multivalent dtp-polio vaccines
AU6065998A (en) Influenza vaccine
AU3423797A (en) Detection of nucleic acids using G-quartets
AU3719500A (en) Recombination of insertion modified nucleic acids

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase